Literature DB >> 30785616

Evaluation of Access to Hospitals Most Ready to Achieve National Accreditation for Rectal Cancer Treatment.

Alexis G Antunez1,2, Arielle E Kanters2,3, Scott E Regenbogen2,3.   

Abstract

Importance: The American College of Surgeons National Accreditation Program for Rectal Cancer (NAPRC) promotes multidisciplinary care to improve oncologic outcomes in rectal cancer. However, accreditation requirements may be difficult to achieve for the lowest-performing institutions. Thus, it is unknown whether the NAPRC will motivate care improvement in these settings or widen disparities.
Objectives: To characterize hospitals' readiness for accreditation and identify differences in the patients cared for in hospitals most and least prepared for accreditation. Design, Setting, and Participants: A total of 1315 American College of Surgeons Commission on Cancer-accredited hospitals in the National Cancer Database from January 1, 2011, to December 31, 2015, were sorted into 4 cohorts, organized by high vs low volume and adherence to process standards, and patient and hospital characteristics and oncologic outcomes were compared. The patients included those who underwent surgical resection with curative intent for rectal adenocarcinoma, mucinous adenocarcinoma, or signet ring cell carcinoma. Data analysis was performed from November 2017 to January 2018. Exposures: Hospitals' readiness for accreditation, as determined by their annual resection volume and adherence to 5 available NAPRC process standards. Main Outcomes and Measures: Hospital characteristics, patient sociodemographic characteristics, and 5-year survival by hospital.
Results: Among the 1315 included hospitals, 38 (2.9%) met proposed thresholds for all 5 NAPRC process standards and 220 (16.7%) met the threshold on 4 standards. High-volume hospitals (≥20 resections per year) tended to be academic institutions (67 of 104 [64.4%] vs 159 of 1211 [13.1%]; P = .001), whereas low-volume hospitals (<20 resections per year) tended to be comprehensive community cancer programs (530 of 1211 [43.8%] vs 28 of 104 [26.9%]; P = .001). Patients in low-volume hospitals were more likely to be older (11 429 of 28 076 [40.7%] vs 4339 of 12 148 [35.7%]; P < .001) and have public insurance (13 054 of 28 076 [46.5%] vs 4905 of 12 148 [40.4%]; P < .001). Low-adherence hospitals were more likely to care for black and Hispanic patients (1980 of 19 577 [17.2%] vs 3554 of 20 647 [10.1%]; P < .001). On multivariable Cox proportional hazards model regression, high-volume hospitals had better 5-year survival outcomes than low-volume hospitals (hazard ratio, 0.99; 95% CI, 0.99-1.00; P < .001), but there was no significant survival difference by hospital process standard adherence. Conclusions and Relevance: Hospitals least likely to receive NAPRC accreditation tended to be community institutions with worse survival outcomes, serving patients at a lower socioeconomic position. To possibly avoid exacerbating disparities in access to high-quality rectal cancer care, the NAPRC study findings suggest enabling access for patients with socioeconomic disadvantage or engaging in quality improvement for hospitals not yet achieving accreditation benchmarks.

Entities:  

Mesh:

Year:  2019        PMID: 30785616      PMCID: PMC6583388          DOI: 10.1001/jamasurg.2018.5521

Source DB:  PubMed          Journal:  JAMA Surg        ISSN: 2168-6254            Impact factor:   14.766


  5 in total

1.  The 13th European Colorectal Congress (#ECCStGallen), 1-5 December 2019, St Gallen, Switzerland: Congress Report.

Authors:  M Adamina; J Douissard; J Lange
Journal:  Tech Coloproctol       Date:  2020-04-16       Impact factor: 3.781

2.  Prognostic factors and patients' profile in treated stage I and II lung adenocarcinoma: a Hospital's Cancer Registry-based analysis.

Authors:  Fernando Conrado Abrão; Stela Verzinhasse Peres; Igor Renato Louro Bruno de Abreu; Riad Naim Younes
Journal:  J Thorac Dis       Date:  2021-11       Impact factor: 2.895

3.  Provider Viewpoints in the Management and Referral of Rectal Cancer.

Authors:  Xiang Gao; Kristin S Weeks; Irena Gribovskaja-Rupp; Imran Hassan; Marcia M Ward; Mary E Charlton
Journal:  J Surg Res       Date:  2020-10-10       Impact factor: 2.192

4.  Hospital and Surgeon Selection for Medicare Beneficiaries With Stage II/III Rectal Cancer: The Role of Rurality, Distance to Care, and Colonoscopy Provider.

Authors:  Catherine Chioreso; Xiang Gao; Irena Gribovskaja-Rupp; Chi Lin; Marcia M Ward; Mary C Schroeder; Charles F Lynch; Elizabeth A Chrischilles; Mary E Charlton
Journal:  Ann Surg       Date:  2021-10-01       Impact factor: 13.787

Review 5.  Quality Assurance, Metrics, and Improving Standards in Rectal Cancer Surgery in the United States.

Authors:  Zhaomin Xu; Fergal J Fleming
Journal:  Front Oncol       Date:  2020-04-29       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.